30 research outputs found

    Génesis, desarrollo y estado actual del espacio rural de Canarias

    Get PDF
    Sobre un espacio frágil, reducido, y de escasos recursos naturales, el canario ha construido un medio rural muy peculiar, que el turismo de los últimos años no ha respetado, compuesto de innumerables teselas epartidas entre los tres pisos bioclimáticos existentes en casi todas sus islas. Lugar de aclimatación de cultivos como la caña de azúcar, o de la patata, fue asiento de productos agrocomerciales como la caña, la vid, la grana, plátano, tomate o flores, junto con un policultivo en terrazas que cubrió la mayor proporción de su espacio agrícola.Genèse, développement et état actuel de l'espace rural des Iles Canaries.- Sur un espace fragile et réduit, dépourvu de ressources naturelles, le Canarien a su construire un espace rural particulier, que le tourisme de ces derniers années n'a pas respecté, composé d'innombrables tesselles répandues sur les trois domaines bioclimatiques présents dans presque toutes les îles. Cet espace fut le lieu d'acclimatation de cultures telles que la canne à sucre ou la pomme de terre, et siège de certaines productions vouées à la commercialisation, comme la canne, le vignoble, la cochenille, la banane, la tomate et les fleurs, sans oublier une policulture sur terrasses qui couvrit la plus grande portion de son espace agricole.Origin, development and present time of the Canarian rural space.- On a fragile, scanty space, lacking of natural resources, the Canarian inhabitant have achieved a particular rural space, severely damaged by tourism in recent years, which was made up with small pieces distributed over the three bioclimatic zones present in almost all the islands. There were acclimated crops like sugarcane and potato, and take seat the commercial agriculture of wine growing, cochineal, bananas, tomatoes or flowers, associated to a farming on terraces which occupied most of the agricultural space.Publicad

    Detection and Tertiary Treatment Technologies of Poly-and Perfluoroalkyl Substances in Wastewater Treatment Plants

    Get PDF
    PFAS are a very diverse group of anthropogenic chemicals used in various consumer and industrial products. The properties that characterize are their low degradability as well as their resistance to water, oil and heat. This results in their high persistence in the environment and bioaccumulation in different organisms, causing many adverse effects on the environment as well as in human health. Some of their effects remain unknown to this day. As there are thousands of registered PFAS, it is difficult to apply traditional technologies for an efficient removal and detection for all. This has made it difficult for wastewater treatment plants to remove or degrade PFAS before discharging the effluents into the environment. Also, monitoring these contaminants depends mostly on chromatography-based methods, which require expensive equipment and consumables, making it difficult to detect PFAS in the environment. The detection of PFAS in the environment, and the development of technologies to be implemented in tertiary treatment of wastewater treatment plants are topics of high concern. This study focuses on analyzing and discussing the mechanisms of occurrence, migration, transformation, and fate of PFAS in the environment, as well the main adverse effects in the environment and human health. The following work reviews the recent advances in the development of PFAS detection technologies (biosensors, electrochemical sensors, microfluidic devices), and removal/degradation methods (electrochemical degradation, enzymatic transformation, advanced oxidation, photocatalytic degradation). Understanding the risks to public health and identifying the routes of production, transportation, exposure to PFAS is extremely important to implement regulations for the detection and removal of PFAS in wastewater and the environment.This work is part of the project entitled “Contaminantes emergentes y prioritarios en las aguas reutilizadas en agricultura: riesgos y efectos en suelos, producción agrícola y entorno ambiental” funded by CSIC-Tecnológico de Monterrey under i-Link + program (LINKB20030).Peer reviewe

    Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks : The GR@ACE project

    Get PDF
    Introduction: Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Methods: Genome Research at Fundacio ACE (GR@ACE) is a genome-wide study of dementia and its clinical endophenotypes, defined based on AD's clinical certainty and vascular burden. We assessed the impact of known AD loci across endophenotypes to generate loci categories. We incorporated gene coexpression data and conducted pathway analysis per category. Finally, to evaluate the effect of heterogeneity in genetic studies, GR@ACE series were meta-analyzed with additional genome-wide association study data sets. Results: We classified known AD loci into three categories, which might reflect the disease clinical heterogeneity. Vascular processes were only detected as a causal mechanism in probable AD. The meta-analysis strategy revealed the ANKRD31-rs4704171 and NDUFAF6-rs10098778 and confirmed SCIMP-rs7225151 and CD33-rs3865444. Discussion: The regulation of vasculature is a prominent causal component of probable AD. GR@ACE meta-analysis revealed novel AD genetic signals, strongly driven by the presence of clinical heterogeneity in the AD series

    Genomic Characterization of Host Factors Related to SARS-CoV-2 Infection in People with Dementia and Control Populations: The GR@ACE/DEGESCO Study

    Get PDF
    Emerging studies have suggested several chromosomal regions as potential host genetic factors involved in the susceptibility to SARS-CoV-2 infection and disease outcome. We nested a COVID-19 genome-wide association study using the GR@ACE/DEGESCO study, searching for susceptibility factors associated with COVID-19 disease. To this end, we compared 221 COVID-19 confirmed cases with 17,035 individuals in whom the COVID-19 disease status was unknown. Then, we performed a meta-analysis with the publicly available data from the COVID-19 Host Genetics Initiative. Because the APOE locus has been suggested as a potential modifier of COVID-19 disease, we added sensitivity analyses stratifying by dementia status or by disease severity. We confirmed the existence of the 3p21.31 region (LZTFL1, SLC6A20) implicated in the susceptibility to SARS-CoV-2 infection and TYK2 gene might be involved in COVID-19 severity. Nevertheless, no statistically significant association was observed in the COVID-19 fatal outcome or in the stratified analyses (dementia-only and non-dementia strata) for the APOE locus not supporting its involvement in SARS-CoV-2 pathobiology or COVID-19 prognosis

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    Nurses' perceptions of aids and obstacles to the provision of optimal end of life care in ICU

    Get PDF
    Contains fulltext : 172380.pdf (publisher's version ) (Open Access

    Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

    Get PDF
    Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson’s disease (PD) and Alzheimer’s disease (AD) versus controls. We demonstrate that the two diseases share the same protective association at the HLA locus. HLA-specific fine-mapping showed that hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1*04:07, and intermediary with HLA-DRB1*04:01 and HLA-DRB1*04:03. The same signal was associated with decreased neurofibrillary tangles in postmortem brains and was associated with reduced tau levels in cerebrospinal fluid and to a lower extent with increased Aβ42. Protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone tau PHF6 sequence, however only when acetylated at a lysine (K311), a common posttranslational modification central to tau aggregation. An HLA-DRB1*04-mediated adaptive immune response decreases PD and AD risks, potentially by acting against tau, offering the possibility of therapeutic avenues
    corecore